VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
LSTA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
LSTALisata Therapeutics, Inc.
$3.27$30M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksLSTAQuarterly Financials

Lisata Therapeutics, Inc. (LSTA) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Lisata Therapeutics, Inc. (LSTA) quarterly income statement — complete revenue, gross profit & net income history

LSTA Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue0100K070K01M00000000000000
Revenue Growth %--90%------------------
Cost of Goods Sold2K0000000000000000000
COGS % of Revenue--------------------
Gross Profit-2K100K070K01M00000000000000
Gross Margin %-100%-100%-100%--------------
Gross Profit Growth %--90%------------------
Operating Expenses4.94M3.18M4.41M4.94M5.85M5.95M5.34M5.52M6.6M6.03M5.96M6.88M6.84M6.54M37.72M6.72M6.62M6.85M6.97M7.15M
OpEx % of Revenue-3179%-7054.29%-594.9%--------------
Selling, General & Admin3.74M2.04M2.46M2.69M3.25M3M2.79M2.92M3.36M3.01M2.58M3.71M3.67M3.37M3.99M3.49M3.34M2.7M2.84M2.82M
SG&A % of Revenue-2045%-3835.71%-299.9%--------------
Research & Development1.2M1.13M1.96M2.25M2.6M2.95M2.54M2.6M3.24M3.01M3.38M3.16M3.18M3.17M33.73M3.23M3.28M4.15M4.13M4.33M
R&D % of Revenue-1134%-3218.57%-295%--------------
Other Operating Expenses00000000000000000000
Operating Income-4.94M-3.08M-4.41M-4.87M-5.85M-4.95M-5.34M-5.52M-6.6M-6.03M-5.96M-6.88M-6.84M-6.54M-37.72M-6.72M-6.62M-6.85M-6.97M-7.15M
Operating Margin %--3079%--6954.29%--494.9%--------------
Operating Income Growth %15.48%37.79%17.28%11.86%11.42%17.86%10.53%19.67%3.55%7.87%84.19%-2.31%-3.38%4.51%-441.33%5.97%18.13%-25.76%-30.24%-66.52%
EBITDA-4.94M-3.06M-4.37M-4.82M-5.8M-4.91M-5.29M-5.48M-6.55M-5.98M-5.92M-6.83M-6.8M-6.49M-37.71M-6.71M-6.61M-6.84M-6.95M-7.13M
EBITDA Margin %--3064%--6891.43%--490.8%--------------
EBITDA Growth %14.89%37.57%17.45%11.94%11.46%17.9%10.53%19.77%3.55%7.93%84.31%-1.71%-2.77%5.09%-442.31%5.85%18.05%-26.01%-30.37%-66.71%
D&A (Non-Cash Add-back)2K15K44K44K43K41K42K45K46K47K47K47K48K47K8K7K7K8K14K17K
EBIT-4.94M-3.08M-4.25M-4.66M-5.85M-4.95M-5.34M-5.52M-6.6M-6.03M-5.96M-6.88M-6.84M-6.54M-37.72M-6.72M-6.62M-6.85M-6.97M-7.15M
Net Interest Income120K00216K266K350K451K493K589K671K714K00-817K000000
Interest Income120K00216K266K350K451K493K589K671K714K00556K000000
Interest Expense00000000000001.37M000000
Other Income/Expense66K125K165K209K161K339K406K479K402K660K703K518K657K550K337K94K-85K55K41K-43K
Pretax Income-4.88M-2.95M-4.25M-4.66M-5.69M-4.61M-4.93M-5.04M-6.2M-5.37M-5.26M-6.36M-6.19M-5.99M-37.38M-6.63M-6.71M-6.79M-6.93M-7.19M
Pretax Margin %--2954%--6655.71%--461%--------------
Income Tax-387K000-962K000-798K00-2.33M0000-2.48M00-1.51M
Effective Tax Rate %7.94%0%0%0%16.92%0%0%0%12.87%0%0%36.65%0%0%0%0%36.97%0%0%20.97%
Net Income-4.49M-2.95M-4.25M-4.66M-4.72M-4.61M-4.93M-5.04M-5.4M-5.37M-5.26M-4.03M-6.19M-5.99M-37.38M-6.63M-4.23M-6.79M-6.93M-5.68M
Net Margin %--2954%--6655.71%--461%--------------
Net Income Growth %4.97%35.92%13.81%7.63%12.53%14.07%6.29%-25.25%12.7%10.43%85.93%39.22%-46.4%11.83%-439.67%-16.61%47.59%-25.1%-30.04%-186.12%
Net Income (Continuing)-4.49M-2.95M-4.25M-4.66M-4.72M-4.61M-4.93M-5.04M-5.4M-5.37M-5.26M-4.03M-6.19M-5.99M-37.38M-6.63M-4.23M-6.79M-6.93M-5.68M
Discontinued Operations00000000000000000000
Minority Interest-254K-254K-254K-254K-254K-254K-254K-254K-254K-254K-254K-254K-254K-254K-254K-254K-254K-254K-254K-254K
EPS (Diluted)-0.50-0.33-0.49-0.54-0.55-0.55-0.59-0.61-0.65-0.66-0.65-0.50-0.77-1.21-7.88-1.60-1.05-1.70-1.74-1.43
EPS Growth %9.09%40%16.95%11.48%15.38%16.67%9.23%-22%15.58%45.45%91.75%68.75%26.67%28.82%-352.87%-11.89%63.41%39.93%59.53%-119.07%
EPS (Basic)-0.50-0.33-0.49-0.54-0.55-0.55-0.59-0.61-0.65-0.66-0.65-0.50-0.77-1.21-7.88-1.60-1.05-1.70-1.74-1.43
Diluted Shares Outstanding9.01M8.69M8.74M8.61M8.6M8.33M8.32M8.31M8.29M8.14M8.14M8.02M7.99M4.96M4.75M4.04M4.04M3.98M3.97M3.97M
Basic Shares Outstanding9.01M8.69M8.74M8.61M8.6M8.33M8.32M8.31M8.29M8.14M8.14M8.02M7.99M4.96M4.75M4.04M4.04M3.98M3.97M3.97M
Dividend Payout Ratio--------------------